Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jounce Therapeutics (JNCE)
NASDAQ:JNCE
Holding JNCE?
Track your performance easily
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 14, 2023 | Kevin Tang Director, >10% Owner | xxxxxxxxxxxxx | $85533 |
| Jan 11, 2023 | Richard Ca Murray Director | xxxxxxxxxxxxx | $50075 |
| Jan 11, 2023 | Drapkin Kimberlee C President, Cfo And Treasurer | xxxxxxxxxxxxx | $15661 |
| Jan 11, 2023 | Hugh Cole Coo | xxxxxxxxxxxxx | $18481 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2023 | xxxxxxxxxxxxx | $18500 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Jounce Therapeutics (JNCE)?
Currently, no data Available
What percentage of Jounce Therapeutics (JNCE) stock is held by institutional investors?
Currently, no data Available
What percentage of Jounce Therapeutics (JNCE) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Jounce Therapeutics (JNCE)?
Currently, no data Available
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.